EcoDrugPlus

Leukotriene A4 Hydrolase

Ensembl ID : ENSBMSG00010009606
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSBMSG00010012150
Gene Symbol: LTB4R2
1 Cross references
238 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSBMSG00010003502
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSBMSG00010001934
Gene Symbol: LOXL2
1 Cross references
288 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSBMSG00010011512
Gene Symbol: MST1R
1 Cross references
268 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSBMSG00010014030
Gene Symbol: MGAM
1 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSBMSG00010006797
Gene Symbol: MMP1
1 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSBMSG00010006744
Gene Symbol: MMP13
1 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSBMSG00010010266
Gene Symbol: MMP14
1 Cross references
272 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSBMSG00010016510
Gene Symbol: MMP2
1 Cross references
210 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSBMSG00010006771
Gene Symbol: MMP3
1 Cross references
502 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSBMSG00010006965
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).